Conmed (CNMD) Other Non-Current Assets (2010 - 2026)

Conmed's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $151.7 million for Q1 2026.

• Quarterly Other Non-Current Assets rose 19.38% year-over-year to $151.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $151.7 million (up 19.38% YoY) and the FY2025 annual result came in at $150.5 million, up 29.34% from the prior year.
• Other Non-Current Assets was $151.7 million for Q1 2026 at Conmed, up from $150.5 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $151.7 million in Q1 2026 and bottomed at $93.9 million in Q4 2022.
• A 5-year average of $117.9 million and a median of $108.0 million in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets dropped 4.98% — and 2025, when it jumped 37.84%.
• Conmed's Other Non-Current Assets stood at $93.9 million in 2022, then grew by 2.38% to $96.1 million in 2023, then climbed by 21.07% to $116.4 million in 2024, then climbed by 29.34% to $150.5 million in 2025, then rose by 0.82% to $151.7 million in 2026.
• Business Quant data shows CNMD's Other Non-Current Assets at $151.7 million in Q1 2026, $150.5 million in Q4 2025, and $148.3 million in Q3 2025.